Alaunos Therapeutics (TCRT) Short-term Investments (2022 - 2023)
Alaunos Therapeutics' (TCRT) quarterly Short-term Investments came in at $13.9 million in Q1 2023, little changed on a QoQ basis from $13.9 million in Q4 2022.
Alaunos Therapeutics (TCRT) Short-term Investments (2022 - 2023) Analysis & Trends
Alaunos Therapeutics (TCRT) has 2 years of Short-term Investments data on file, last reported at $13.9 million in Q1 2023.
- Quarterly Short-term Investments changed N/A year-over-year to $13.9 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $13.9 million (changed N/A YoY) and the FY2022 annual result came in at $13.9 million, changed N/A from the prior year.
- Short-term Investments steadied at $13.9 million in Q1 2023, from $13.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $13.9 million in Q3 2022 to a low of $13.9 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 13.94 Mn |
| Dec 31, 2022 | 13.94 Mn |
| Sep 30, 2022 | 13.94 Mn |